Access Program Information
Early Access Program to provide L-asparaginase encapsulated in Erythrocyte (GRASPA®) for
patient unable to receive any other form of Asparaginase.
ERYtech Pharma – Acute Lymphoblastic Leukemia
Rare Disease:
- Home
- /
- Access Program
- /
- ERYtech Pharma – Acute...